- Visibility 73 Views
- Downloads 18 Downloads
- Permissions
- DOI 10.18231/2581-3706.2018.0009
-
CrossMark
- Citation
Correlation of VEGF and HIF-1α in breast carcinoma (an immunohistochemical study)
- Author Details:
-
Saumil Garg
-
Manas Madan
-
Manisha Sharma
-
Mridu Manjari
-
Sanjay Piplani
Introduction: By 2030 the incidence of breast cancer in India will increase to around 200,000 per year. During tumor growth, angiogenesis is induced by many stimuli. Reduced oxygen stimulates hypoxia induced factor 1 alpha (HIF-1?), activating proangiogenic cytokines i.e. vascular endothelial growth factor (VEGF). The best-studied factor is VEGF-A. Overexpression of HIF promotes metastasis of cancers. Higher the levels of VEGF, poorer the prognosis. HIF-1? is an independent prognostic factor for an unfavorable prognosis.
Materials and Methods: Study was conducted on 50 cases of breast cancer specimens. Histopathological typing and grading was done followed by immunohistochemistry for HIF-1? expression. Serum samples were collected for VEGF levels.
Observations and Results: Most patients were in the age group of 41-60 years. 94% of the tumors were infiltrating ductal carcinoma NOS the remaining being mucinous (4%) and tubular (2%). 16 cases were Grade II and 34 cases were Grade III. Lymph nodes were recovered in 44 cases of radical mastectomy. Metastatic carcinomatous deposits were present in 26 cases. Lynphovascular invasion (LVI) was seen in 20 cases. sVEGF levels were increased in 21 cases. No correlation was seen with grade of tumor whereas a positive correlation was seen with LVI and lymph node status. No positive correlation was seen with HIF-1? and all these parameters. No significant correlation was seen between sVEGF levels and HIF-1?.
Conclusion: sVEGF levels have direct relationship with LVI and lymph node status and should be taken as a poor prognostic factor. HIF-1? was increased more in high grade tumors but had no statistical significance with LVI and lymph node status.
Keywords: Breast cancer, VEGF, HIF-1?, Immunohistochemistry.
References
- Kumar P, Bolshette NB, Jamdade VS, Mundhe NA, Thakur KK, Saikia KK. Breast cancer status in India: An overview. Biomedicine & Preventive Nutrition. 2013;3(2):177-83.
- Stricker TP, Kumar V. Neoplasia. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran Pathologic Basis of Disease. 8th Ed. Philadelphia: Saunders; 2010. p. 297-8.
- Saponaro C, Malfettone A, Ranieri G, Danza K, Simone G, Paradiso A et al. VEGF, HIF-1α Expression and MVD as an angiogenic network in familial breast cancer. PLoS One. 2013;8(1):e53070.. doi:10.1371/journal.pone.0053070
[Google Scholar] Epub 2013 Jan 11. - Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine Rev. 2004;25(4):581-611.
- Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature Medicine. 2003;9:669-76. Saumil Garg et al. Correlation of VEGF and HIF-1α in breast carcinoma…… IP Journal of Diagnostic Pathology and Oncology, January-March,2018;3(1):40-44 44
- Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem. 1996;271(30):17771-8.
- Li JY, Zhang Y, Zhang WH, Jia S, Kang Y, Zhu XY. Differential distribution of miR-20a and miR-20b may underlie metastatic heterogeneity of breast cancers. Asian Pacific J Cancer Prev. 2012;13(5):1901-6.
- Saxena S, Rekhi B, Bansal A, Bagga A, Chintamani, Murthy NS. Clinico-morphological patterns of breast cancer study. World J Surg Oncol. 2005;3:67.
- Hussain MA, Ali S, Tyagi SP, Reza H. Incidence of cancer breast at Aligarh. J Indian Med Assoc. 1994;92(9):296-7.
- Gruber G, Greiner RH, Hlushchuk R, Aebersold DM, Altermatt HJ, Berclaz G, Djonov V. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res. 2004;6(3):191-
- Ambroise M, Ghosh M, Mallikarjuna VS, Kurian A. Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India. Asian Pac J Cancer Prev. 2011;12(3):625-9.
- Dales JP, Garcia S, Meunier-Carpentier S, Andrac-Meyer L, Haddad O, Lavaut MN, et al. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int J Cancer. 2005 Sep 20;116(5):734-9.
- Rosai J. The Breast. In: Rosai and Ackerman’s Surgical Pathology. 9th Ed (Vol.2). New York: Mosby Elsevier;
- p. 1763-876.
- Shet T, Agrawal A, Nadkarni M, Palkar M, Havaldar R, Parmar V, Badwe R, Chinoy RF. Hormone receptors over the last 8 years in a cancer referral centre in India: What was and what is? Indian J Pathol Microbiol. 2009;52(2):171-4.
- Chanana P, Pandey AK, Yadava BS, Kaur J, Singla S, Dimri K, et al. Significance of serum vascular endothelial growth factor and cancer antigen 15.3 in patients with triple negative breast cancer. J Radiotherap Prac. 2014 Mar;13(1):60-7.
- Kapahi R, Manjari M, Uppal MS, Singh NR, Sambyal V, Guleria K. Association of 2549 Insertion/Deletion Polymorphism of Vascular Endothelial Growth Factor with Breast Cancer in North Indian Patients. Genet Test Mol Biomarkers. 2013;17(3):242-8.
- Pande D, Negi R, Khanna S, Khanna R, Khanna HD. Vascular endothelial growth factor levels in relation to oxidative damage and antioxidant status in patients with breast cancer. J Breast Cancer. 2011;14(3):181-4.
- Ni X, Zhao Y, Ma J, Xia T, Liu X, Ding Q, et al. Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients. J Biomed Res. 2013;27(6):478–85.
- Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer. 2003;97(6):1573-81.
- Ali EM, Sheta M, El Mohsen MA. Elevated serum and tissue VEGF associated with poor outcome in breast cancer patients. Alexandria J Med. 2011;47:217-24.
- Vicioso L, Gonzalez FJ, Alvarez M, Ribelles N, Molina M, Marquez A, et al. Elevated Serum Levels of Vascular Endothelial Growth Factor Are Associated With Tumor- Associated Macrophages in Primary Breast Cancer. Am J Clin Pathol. 2006;125:111-8.
How to Cite This Article
Vancouver
Garg S, Madan M, Sharma M, Manjari M, Piplani S. Correlation of VEGF and HIF-1α in breast carcinoma (an immunohistochemical study) [Internet]. IP J Diagn Pathol Oncol. 2018 [cited 2025 Oct 07];3(1):40-44. Available from: https://doi.org/10.18231/2581-3706.2018.0009
APA
Garg, S., Madan, M., Sharma, M., Manjari, M., Piplani, S. (2018). Correlation of VEGF and HIF-1α in breast carcinoma (an immunohistochemical study). IP J Diagn Pathol Oncol, 3(1), 40-44. https://doi.org/10.18231/2581-3706.2018.0009
MLA
Garg, Saumil, Madan, Manas, Sharma, Manisha, Manjari, Mridu, Piplani, Sanjay. "Correlation of VEGF and HIF-1α in breast carcinoma (an immunohistochemical study)." IP J Diagn Pathol Oncol, vol. 3, no. 1, 2018, pp. 40-44. https://doi.org/10.18231/2581-3706.2018.0009
Chicago
Garg, S., Madan, M., Sharma, M., Manjari, M., Piplani, S.. "Correlation of VEGF and HIF-1α in breast carcinoma (an immunohistochemical study)." IP J Diagn Pathol Oncol 3, no. 1 (2018): 40-44. https://doi.org/10.18231/2581-3706.2018.0009